HUP0302664A2 - Vakcináció gazdasejttel asszociált herpeszvírusok ellen - Google Patents
Vakcináció gazdasejttel asszociált herpeszvírusok ellenInfo
- Publication number
- HUP0302664A2 HUP0302664A2 HU0302664A HUP0302664A HUP0302664A2 HU P0302664 A2 HUP0302664 A2 HU P0302664A2 HU 0302664 A HU0302664 A HU 0302664A HU P0302664 A HUP0302664 A HU P0302664A HU P0302664 A2 HUP0302664 A2 HU P0302664A2
- Authority
- HU
- Hungary
- Prior art keywords
- vaccination against
- host cell
- against host
- herpesviruses
- marek
- Prior art date
Links
- 238000002255 vaccination Methods 0.000 title abstract 4
- 241001529453 unidentified herpesvirus Species 0.000 title abstract 2
- 241000701085 Human alphaherpesvirus 3 Species 0.000 abstract 2
- 201000006082 Chickenpox Diseases 0.000 abstract 1
- 241000701047 Gallid alphaherpesvirus 2 Species 0.000 abstract 1
- 208000007514 Herpes zoster Diseases 0.000 abstract 1
- 208000006758 Marek Disease Diseases 0.000 abstract 1
- 208000027954 Poultry disease Diseases 0.000 abstract 1
- 206010046980 Varicella Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 244000144977 poultry Species 0.000 abstract 1
- 230000007420 reactivation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A találmány tárgya úgynevezett gazdasejttel asszociált herpeszvírusok,például baromfik Marek-féle betegségének vírusa (MDV) és emberekbenelőforduló Varicella Zoster vírus (VZV, amely csirkehimlőt és zostertokoz látenciából való reaktiválódás után) elleni vakcináció és azilyen vírusok által okozott betegségek elleni vakcinációszakterületére tartozik, közelebbről baromfibetegségek, különösen aMarek-féle betegség elleni vakcináció területére. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00202757A EP1178111A1 (en) | 2000-08-03 | 2000-08-03 | Vaccination against host cell-associated herpesviruses |
PCT/EP2001/008893 WO2002012288A2 (en) | 2000-08-03 | 2001-08-01 | Vaccination against host cell-associated herpesviruses |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP0302664A2 true HUP0302664A2 (hu) | 2003-11-28 |
HUP0302664A3 HUP0302664A3 (en) | 2004-10-28 |
HU228262B1 HU228262B1 (en) | 2013-02-28 |
Family
ID=8171884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0302664A HU228262B1 (en) | 2000-08-03 | 2001-08-01 | Vaccination against host cell-associated herpesviruses |
Country Status (24)
Country | Link |
---|---|
US (1) | US9073979B2 (hu) |
EP (2) | EP1178111A1 (hu) |
JP (1) | JP4313036B2 (hu) |
KR (1) | KR100633180B1 (hu) |
CN (2) | CN102151333A (hu) |
AT (1) | ATE412055T1 (hu) |
AU (2) | AU2001291716B2 (hu) |
BR (1) | BRPI0112989B1 (hu) |
CA (1) | CA2417923C (hu) |
CZ (1) | CZ303904B6 (hu) |
DE (1) | DE60136278D1 (hu) |
EA (1) | EA010721B1 (hu) |
ES (1) | ES2315306T3 (hu) |
HR (1) | HRP20030147B1 (hu) |
HU (1) | HU228262B1 (hu) |
IL (2) | IL154250A0 (hu) |
MX (1) | MXPA03001027A (hu) |
NO (1) | NO332621B1 (hu) |
NZ (1) | NZ524066A (hu) |
PL (1) | PL207958B1 (hu) |
PT (1) | PT1307565E (hu) |
UA (1) | UA84667C2 (hu) |
WO (1) | WO2002012288A2 (hu) |
ZA (1) | ZA200300842B (hu) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1178111A1 (en) | 2000-08-03 | 2002-02-06 | Lohmann Animal Health GmbH & Co. KG | Vaccination against host cell-associated herpesviruses |
WO2005085445A1 (ja) * | 2004-03-05 | 2005-09-15 | The Research Foundation For Microbial Diseases Of Osaka University | 組換え水痘帯状疱疹ウイルス |
US9273326B2 (en) | 2004-04-30 | 2016-03-01 | The Brigham And Women's Hospital, Inc. | Tetracycline-regulated gene expression in HSV-1 vectors |
US20080226677A1 (en) * | 2004-05-06 | 2008-09-18 | Yasuko Mori | Recombinant virus vector for gene transfer into lymphoid cells |
EP3756684A1 (en) | 2009-05-22 | 2020-12-30 | Genocea Biosciences, Inc. | Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
US8809047B2 (en) | 2009-12-21 | 2014-08-19 | The Brigham And Women's Hospital, Inc. | Herpes simplex virus vaccines |
US9782474B2 (en) * | 2010-11-24 | 2017-10-10 | Genocea Biosciences, Inc. | Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
ES2700243T3 (es) * | 2011-10-21 | 2019-02-14 | Intervet Int Bv | Construcciones del virus de la enfermedad de Marek recombinantes no patógenas que codifican antígenos del virus de la laringotraqueitis infecciosa y del virus de la enfermedad de Newcastle |
EP2782597B1 (en) * | 2011-11-23 | 2022-04-13 | Genocea Biosciences, Inc. | Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
CN105597095A (zh) * | 2015-12-30 | 2016-05-25 | 暨南大学 | 一种应用微载体培养Vero细胞制备基因缺失减毒疫苗的方法 |
CN105561303B (zh) * | 2015-12-30 | 2019-04-05 | 暨南大学 | 单纯疱疹病毒i型ul5基因缺失的dna疫苗的制备方法 |
CN105641692A (zh) * | 2015-12-30 | 2016-06-08 | 暨南大学 | 单纯疱疹病毒ⅰ型基因重组减毒活疫苗及其制备方法 |
JP2019537555A (ja) | 2016-09-28 | 2019-12-26 | ジェノセア バイオサイエンシーズ, インコーポレイテッド | ヘルペスを処置するための方法および組成物 |
US11174322B2 (en) * | 2017-07-24 | 2021-11-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Antibodies and peptides to treat HCMV related diseases |
BR112020012162A2 (pt) * | 2017-12-20 | 2020-11-24 | Intervet International B.V. | diluente aprimorado para vacina contra alfa-herpesvírus associado à célula |
WO2019152821A1 (en) | 2018-02-05 | 2019-08-08 | The Brigham And Women's Hospital, Inc. | Recombinant herpes simplex virus-2 expressing glycoprotein b and d antigens |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3959466A (en) * | 1974-04-15 | 1976-05-25 | The Wistar Institute | Highly attenuated cytomegalovirus vaccine and production thereof |
GB8821441D0 (en) | 1988-09-13 | 1988-10-12 | Animal Health Inst | Viral vectors |
EP0486106A3 (en) | 1990-11-16 | 1992-12-23 | Akzo N.V. | Marek's disease virus vaccine |
AU657144B2 (en) * | 1991-07-09 | 1995-03-02 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same |
JP3675569B2 (ja) | 1995-04-28 | 2005-07-27 | 日本ゼオン株式会社 | 組み換えウイルス及びそれよりなるワクチン |
KR19990028766A (ko) | 1995-07-07 | 1999-04-15 | 나카노 가쓰히꼬 | 마렉 질환 바이러스 유전자 및 마렉 질환 예방용 백신에서그의 용도 |
US6306387B1 (en) * | 1997-05-29 | 2001-10-23 | The Research Foundation Of State University Of New York | Antigen delivery system |
DE19733364A1 (de) * | 1997-08-01 | 1999-02-04 | Koszinowski Ulrich H Prof | Verfahren zur Klonierung eines großen Virusgenoms |
AUPP684998A0 (en) * | 1998-10-30 | 1998-11-26 | Murdoch Institute for Research into Birth Defects Limited, The | A method of recombination and agents useful for same |
EP1038952A3 (en) | 1998-12-09 | 2001-06-27 | Pfizer Products Inc. | Processes for preparation of Marek's Disease Virus using continuous avian cell lines |
US6410222B1 (en) * | 1998-12-14 | 2002-06-25 | Juridical Foundation The Chemosero-Therapeutic Research Institute | In ovo vaccination of marek's disease type I virus |
US6299882B1 (en) | 1999-04-09 | 2001-10-09 | Schering Corporation | UL54.5 of Marek's disease virus (MDV) |
EP1178111A1 (en) | 2000-08-03 | 2002-02-06 | Lohmann Animal Health GmbH & Co. KG | Vaccination against host cell-associated herpesviruses |
-
2000
- 2000-08-03 EP EP00202757A patent/EP1178111A1/en not_active Withdrawn
-
2001
- 2001-01-08 UA UA2003021829A patent/UA84667C2/ru unknown
- 2001-08-01 JP JP2002518259A patent/JP4313036B2/ja not_active Expired - Lifetime
- 2001-08-01 EA EA200300215A patent/EA010721B1/ru not_active IP Right Cessation
- 2001-08-01 KR KR1020037001366A patent/KR100633180B1/ko active IP Right Grant
- 2001-08-01 CN CN2011100310998A patent/CN102151333A/zh active Pending
- 2001-08-01 WO PCT/EP2001/008893 patent/WO2002012288A2/en active IP Right Grant
- 2001-08-01 EP EP01971839A patent/EP1307565B1/en not_active Expired - Lifetime
- 2001-08-01 ES ES01971839T patent/ES2315306T3/es not_active Expired - Lifetime
- 2001-08-01 PL PL365190A patent/PL207958B1/pl unknown
- 2001-08-01 CN CNA018167950A patent/CN1503843A/zh active Pending
- 2001-08-01 AU AU2001291716A patent/AU2001291716B2/en not_active Ceased
- 2001-08-01 CA CA2417923A patent/CA2417923C/en not_active Expired - Lifetime
- 2001-08-01 BR BRPI0112989A patent/BRPI0112989B1/pt active IP Right Grant
- 2001-08-01 HU HU0302664A patent/HU228262B1/hu unknown
- 2001-08-01 NZ NZ524066A patent/NZ524066A/en not_active IP Right Cessation
- 2001-08-01 DE DE60136278T patent/DE60136278D1/de not_active Expired - Lifetime
- 2001-08-01 AU AU9171601A patent/AU9171601A/xx active Pending
- 2001-08-01 PT PT01971839T patent/PT1307565E/pt unknown
- 2001-08-01 MX MXPA03001027A patent/MXPA03001027A/es active IP Right Grant
- 2001-08-01 CZ CZ20030324A patent/CZ303904B6/cs not_active IP Right Cessation
- 2001-08-01 AT AT01971839T patent/ATE412055T1/de active
- 2001-08-01 IL IL15425001A patent/IL154250A0/xx unknown
-
2003
- 2003-01-30 ZA ZA200300842A patent/ZA200300842B/en unknown
- 2003-01-30 US US10/354,932 patent/US9073979B2/en active Active
- 2003-02-02 IL IL154250A patent/IL154250A/en not_active IP Right Cessation
- 2003-02-03 NO NO20030524A patent/NO332621B1/no not_active IP Right Cessation
- 2003-02-28 HR HR20030147A patent/HRP20030147B1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0302664A2 (hu) | Vakcináció gazdasejttel asszociált herpeszvírusok ellen | |
Arvin et al. | Human herpesviruses: biology, therapy, and immunoprophylaxis | |
Mettenleiter | Molecular biology of pseudorabies (Aujeszky's disease) virus | |
ES2261243T3 (es) | Composiciones de vacuna combinada. | |
WO2000061736A3 (en) | Recombinant and mutant marek's disease virus | |
EA200701633A1 (ru) | Вакцина на основе вирусоподобных частиц вируса папилломы человека 16 и вируса папилломы человека 18 l1 | |
Field et al. | Herpesvirus latency and therapy—from a veterinary perspective | |
HUP0102861A2 (hu) | Attenuált lóherpeszvírus | |
MX9605139A (es) | Linea celular de pollo, sostenible, infectada con el virus de la enfermedad de marek. | |
HUP0001991A2 (hu) | Varicella Zoster vírus 63-as géntermékkel szembeni vakcinák | |
DE68929181D1 (de) | Virale nucleotidsequenzen | |
Wyrwicz et al. | Herpes glycoprotein gL is distantly related to chemokine receptor ligands | |
Mariappan et al. | Marek’s disease virus | |
Oh et al. | Effect of smoked tobacco tar on the growth, cytolytic action, DNA synthesis, and gene expression of herpes simplex virus | |
HUP0202738A2 (hu) | Ló herpeszvírus hőérzékeny mutánsa és az abból készített élő oltóanyag | |
BR0304750A (pt) | Mutante de herpesvìrus bovino tipo 5, vacina dirigida contra a encefalite viral bovina (bhv-s) e o vìrus rábico e método de preparação da vacina | |
AU2003298838A1 (en) | Escape mutants of newcastle disease virus as marker vaccines | |
Junker | UL 54. 5 of Marek's disease virus(MDV) | |
RU95104923A (ru) | Штамм вируса герпеса кур "42" - деп для изготовления вакцины против болезни марека | |
Reddy et al. | Novel insights in the pathogenesis of infectious laryngotracheitis and bronchitis viruses in chickens | |
RU95104924A (ru) | Штамм вируса герпеса кур "50" - деп для изготовления вакцины против болезни марека | |
Bourne et al. | Pathogenesis of Drug Resistant Clinical HSV-2 Isolates in the Guinea Pig Model of Genital Herpes. | |
RU94042470A (ru) | Поливалентная вакцина для профилактики болезни марека и способ ее изготовления |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB9A | Succession in title |
Owner name: ELANCO TIERGESUNDHEIT AG, CH Free format text: FORMER OWNER(S): LOHMANN ANIMAL HEALTH GMBH & CO. KG, DE; LOHMANN ANIMAL HEALTH GMBH, DE |